Grace Patterson, Research Scientist at Crescendo Biologics Limited

Grace Patterson

Research Scientist at Crescendo Biologics Limited | United Kingdom

Profile last verified August 2026
Biotechnology Research Verified Profile United Kingdom University of Kent
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

+44 ** **** *396

United Kingdom • Phone

Free account · No credit card · 5 profiles/month

Grace Patterson Socials
Grace Patterson Work Experience

Research Scientist at Crescendo Biologics Limited in February 2024 - Present

Research Assistant -Discovery at Crescendo Biologics Limited in June 2022 - March 2024

Genetic Technologist at Oncologica UK in July 2021 - April 2022

Grace Patterson Education

University of Kent, Bachelor of Science - BSc, January 2018 to January 2021

Rainham Mark Grammar School, January 2016 to January 2018

Chatham Grammar School For Girls, January 2011 to January 2016

About Grace Patterson’s Current Company
Crescendo Biologics Limited

Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical candidate from Crescendo’s T cell enhancing pipeline. Crescendo is also developing CB213, a preclinical PD-1 x LAG-3 multi-specific Humabody. The Company’s ability to develop multi-functional Humabody therapeutics is based on its unique, patent protected, transgenic mouse platform generating fully human VH domain building blocks (Humabody VH). These robust molecules can be configured to engage therapeutic targets in such a way that they deliver novel pharmacology and superior bio-distribution. This can lead to larger therapeutic windows compared to conventional IgG approaches. Humabody-based formats can also be applied across a range of non-cancer indications. Beyond Crescendo’s proprietary pipeline, the Company has global, multi-target discovery and development collaborations with both Takeda and BioNTech and an exclusive, worldwide licensing agreement with Zai Lab for ZL-1102 (formerly CB001, an anti-IL-17A targeting Humabody), which is expected to enter global Phase 2 clinical development in patients with psoriasis. Crescendo Biologics is located in Cambridge, UK, and is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda and Quan Capital. For more information, please visit www.crescendobiologics.com.

Discover more about Crescendo Biologics Limited
Grace Patterson’s Colleagues
Deanna Patmore

Deanna Patmore

Cambridge, England, United Kingdom

Senior Project Manager at Crescendo Biologics

Senior Project Manager, Early Stage R&D at Crescendo Biologics Limited
(March 2022 – Present)

Holly Spencer

Holly Spencer

Cambridge, England, United Kingdom

Research Scientist at Crescendo Biologics Ltd (Translational Team) | MSc (Med), with skills in Molecular Biology, Immunology, and Genetics

Research Associate at Crescendo Biologics Limited
(May 2022 – Present)

Eleanor Moffitt

Eleanor Moffitt

Cambridge, England, United Kingdom

Research Associate at Crescendo Biologics

Research Associate at Crescendo Biologics Limited
(August 2021 – Present)

Giada Gaviano

Giada Gaviano

Huntingdon, England, United Kingdom

Laboratory Analyst

Research Assistant at Crescendo Biologics Limited
(May 2022 – Present)

Elena Sofocleous

Elena Sofocleous

United Kingdom

Research Assistant at Crescendo Biologics

Research Assistant at Crescendo Biologics Limited
(August 2023 – Present)

Daniela Sydoruk

Daniela Sydoruk

Greater Cambridge Area

Senior Scientist at Crescendo Biologics Limited

Principal Scientist at Crescendo Biologics Limited
(February 2024 – Present)

Search similar profiles
Frequently asked questions about Grace Patterson

What is Grace Patterson email address?

Email Grace Patterson at [email protected] and [email protected]. This email is the most updated Grace Patterson's email found in 2026.

How to contact Grace Patterson?

To contact Grace Patterson send an email to [email protected] or [email protected].

What company does Grace Patterson work for?

Grace Patterson works for Crescendo Biologics Limited.

What is Grace Patterson's role at Crescendo Biologics Limited?

Grace Patterson is Research Scientist

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free